Emerging Technologies

A manufacturer of compact MRI machines that leverage AI to upgrade image quality has received FDA’s blessing to market its technology in the U.S.

The advance represents the first cancer-care pathway offering an automatically combined analysis of morphological, molecular and histological data. 

The COVID crisis has spurred clinical researchers to look myriad ways AI might help win the war against the virus. Has the investigatory boomlet ended up raising as many nettlesome concerns as positive possibilities?

Emergency-room patients are happy to receive care from a physician interacting remotely over a tablet computer mounted on a dog-like robot.

Harvard researchers have used machine learning to find molecular features in existing drugs that may be effective in warding off or treating Alzheimer’s disease.

Researchers in Italy have demonstrated a no-cost, AI-based technique for detecting the presence of previously undiagnosed abnormalities in blood sugar stability.

Clinical laboratories store a motherlode of objective and structured patient data well primed for mining with AI. Given this reality, pathologists and medical laboratorians must set and abide by principles guiding the ethical use of the technology.

A survey of ICU doctors and nurses at Mayo Clinic reveals widespread concern over lawsuits connected to the proposed use of video recording and video recognition with computer vision.

If verified in additional trials, the advance will facilitate care planning much earlier than the current average age of diagnosis, 4 years old.

An AI decision aid significantly improved decision quality, level of shared decision-making, patient satisfaction and functional outcomes in patients compared to an education-only approach, according to a new study in JAMA.

The reported exploration to sell Watson Health, the AI-driven health business of IBM, underscores deep challenges with technology in solving healthcare problems, according to the Wall Street Journal.


AI can be taught to flag possible skin cancers on photos taken with smartphone cameras—and the images can be ordinary “people shots” rather than closeups of suspicious lesions.

Around the web

Two different companies announced that they are recalling all lots of the medication. 

CardioSmart, an online resource for both patients and clinicians, has a new editor. 

The funding includes $8.5 billion in American Rescue Plan resources for providers who treat Medicaid, Children's Health Insurance Program and Medicare patients.

Trimed Popup
Trimed Popup